SOLICITATION NOTICE
65 -- qty 10 of Cat#A14525 EXPIFECTAMINE TRANSFXN KIT 10L
- Notice Date
- 11/6/2020 8:33:30 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- NIH National Institute of Allergy and Infectious Diseases Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- RFQ-NIH-NIAID-2046549
- Response Due
- 11/16/2020 7:00:00 AM
- Archive Date
- 12/01/2020
- Point of Contact
- Lorena Waller, Phone: 2406695099, Skye Duffner, Phone: 4068026092
- E-Mail Address
-
Wallerlor@niaid.nih.gov, skye.duffner@nih.gov
(Wallerlor@niaid.nih.gov, skye.duffner@nih.gov)
- Description
- This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 �Streamlined Procedures for Evaluation and solicitation for commercial Items,� as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2046549 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2020-09, Effective 10/26/2020.� The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (except Diagnostic) Manufacturing., with 1250 employees. This is a BRAND NAME requirement and is not set-aside for small business. Background: The Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The mission of the Vaccine Research Center (VRC) is to conduct research that facilitates the development of effective vaccines for human disease. The virology core section of the VRC is developing vaccines for HIV-1 and other viruses. Production of various wild type and mutant viral proteins is critical in vaccine development. These viral proteins need to be expressed in cell lines. Description and purpose of the Requirement: The Expifectamine Transfection kit reagent is specific for suspension of 293 cell lines and has been proven to support and improve proteins expression for our protocols. Therefore we must maintain reagent standards to insure experimental results are not influenced by other variables. Proteins so made will be used in for structural analysis and pre-clinical animal studies. Item # A14525 EXPIFECTAMINE TRANSFXN KIT 10L QTY 10 Expedited delivery required. Delivery date: 10 days ARO ALL OFFERORS MUST ALSO COMPLETE AND SIGN THE ATTACHED CERTIFICATION (VENDOR CERTIFICATION) Place of Performance: Bldg 40 at 9000 Rockville Pike, Bethesda, MD 20892 *Please include your DUNS number on quote *Include response to FAR 52.204-26 and (52.204-24 if applicable) and return with quote Submission shall be received not later than 10:00 a.m. EST, November 16, 2020. The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.� The award will be based on the following; price, capability to meet the requirements, delivery and the best value to the government. The following FAR provisions apply to this acquisition: FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Oct 2020) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-1 Instructions to Offerors Commercial Items (Jun 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Oct 2020) Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements � Representation (Jan 2017) The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (Oct 2018) FAR 52-212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Oct 2020) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.203-19 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Jan 2017) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015) By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Offers may be mailed or e-mailed to Ms. Lorena Waller, (E-Mail/ Wallerlor@niaid.nih.gov). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) (June 2020) All responsible sources may submit an offer that will be considered by this Agency.� Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Ms.Wallerlor@niaid.nih.gov.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/b54ef3270b4d4b4db545e52ea74e2c66/view)
- Place of Performance
- Address: Bethesda, MD 20892, USA
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN05848455-F 20201108/201106230146 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |